| Literature DB >> 33863824 |
Gyu Seong Heo1, Lanlan Lou1, Deborah Sultan1, Yongjian Liu2.
Abstract
Inflammation and fibrosis are hallmarks of tissue repair processes and organ failure progression in cardiovascular diseases. Paradigm-shifting research on diverse immune cell populations within the cardiovascular system have enabled discovery of new biomarkers fostering development of diagnostic and therapeutic agents at the molecular level to better manage cardiovascular diseases. To date, a variety of molecular imaging agents have been developed to visualize the biomarkers expressed on immune cells and fibroblasts within their crosstalk network, which drives the pathogenesis of fibrosis triggered by both innate and adaptive immunity. Herein, key biomarkers upregulated in the immune-fibrosis axis are discussed. The promising molecular imaging agents to reveal this critical pathologic process are summarized.Entities:
Keywords: cardiovascular diseases; fibrosis; immune system; inflammation; molecular imaging
Mesh:
Year: 2021 PMID: 33863824 PMCID: PMC8724900 DOI: 10.2967/jnumed.120.255539
Source DB: PubMed Journal: J Nucl Med ISSN: 0161-5505 Impact factor: 10.057